iA Global Asset Management Inc. Invests $258,000 in Teleflex Incorporated (NYSE:TFX)

iA Global Asset Management Inc. bought a new stake in Teleflex Incorporated (NYSE:TFX) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,448 shares of the medical technology company’s stock, valued at approximately $258,000.

A number of other hedge funds have also added to or reduced their stakes in the business. Magnetar Financial LLC grew its position in Teleflex by 105.2% in the fourth quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company’s stock valued at $74,990,000 after purchasing an additional 215,961 shares in the last quarter. Boston Partners grew its position in Teleflex by 1,561.5% in the fourth quarter. Boston Partners now owns 148,042 shares of the medical technology company’s stock valued at $26,351,000 after purchasing an additional 139,132 shares in the last quarter. Generali Asset Management SPA SGR bought a new position in Teleflex in the fourth quarter valued at $77,000. William Blair Investment Management LLC grew its position in Teleflex by 20.7% in the fourth quarter. William Blair Investment Management LLC now owns 2,654 shares of the medical technology company’s stock valued at $472,000 after purchasing an additional 456 shares in the last quarter. Finally, Cibc World Markets Corp grew its position in Teleflex by 14.4% in the fourth quarter. Cibc World Markets Corp now owns 7,340 shares of the medical technology company’s stock valued at $1,306,000 after purchasing an additional 925 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Stock Performance

NYSE TFX opened at $141.77 on Friday. The firm has a 50-day moving average of $163.17 and a 200-day moving average of $194.04. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock has a market cap of $6.57 billion, a PE ratio of 28.19, a P/E/G ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 52-week low of $128.55 and a 52-week high of $249.91.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.96%. The ex-dividend date was Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is 95.77%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on TFX. Citizens Jmp downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Raymond James downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.